RHUMBLINE ADVISERS - ADAPTIVE BIOTECHNOLOGIES COR ownership

ADAPTIVE BIOTECHNOLOGIES COR's ticker is ADPT and the CUSIP is 00650F109. A total of 223 filers reported holding ADAPTIVE BIOTECHNOLOGIES COR in Q4 2022. The put-call ratio across all filers is 0.03 and the average weighting 0.1%.

Quarter-by-quarter ownership
RHUMBLINE ADVISERS ownership history of ADAPTIVE BIOTECHNOLOGIES COR
ValueSharesWeighting
Q3 2023$873,179
-17.2%
160,219
+1.9%
0.00%0.0%
Q2 2023$1,055,147
+66978.6%
157,250
-11.8%
0.00%
-50.0%
Q1 2023$1,573
+19.7%
178,197
+3.6%
0.00%0.0%
Q4 2022$1,314
-99.9%
172,014
+0.9%
0.00%0.0%
Q3 2022$1,214,000
-6.4%
170,464
+6.3%
0.00%0.0%
Q2 2022$1,297,000
-2.9%
160,373
+66.6%
0.00%0.0%
Q1 2022$1,336,000
-53.9%
96,252
-6.8%
0.00%
-50.0%
Q4 2021$2,897,000
-13.5%
103,228
+4.8%
0.00%
-20.0%
Q3 2021$3,348,000
-17.9%
98,489
-1.3%
0.01%0.0%
Q2 2021$4,079,000
+32.1%
99,818
+30.2%
0.01%
+25.0%
Q1 2021$3,087,000
-39.2%
76,682
-10.8%
0.00%
-42.9%
Q4 2020$5,081,000
+24.4%
85,928
+2.3%
0.01%
+16.7%
Q3 2020$4,085,000
+5.3%
84,000
+4.7%
0.01%0.0%
Q2 2020$3,881,000
+132.7%
80,225
+33.6%
0.01%
+100.0%
Q1 2020$1,668,000
+255.7%
60,046
+283.4%
0.00%
+200.0%
Q4 2019$469,000
+33.6%
15,660
+37.7%
0.00%0.0%
Q3 2019$351,00011,3690.00%
Other shareholders
ADAPTIVE BIOTECHNOLOGIES COR shareholders Q4 2022
NameSharesValueWeighting ↓
Blue Water Life Science Advisors, LP 2,377,665$12,958,27412.23%
Eagle Health Investments LP 1,214,860$6,620,9871.46%
Matrix Capital Management Company, LP 11,572,590$63,070,6160.76%
Aristotle Atlantic Partners, LLC 3,058,206$16,667,2230.67%
VIKING GLOBAL INVESTORS LP 29,993,708$163,465,7090.66%
Pier Capital, LLC 719,067$3,918,9150.63%
DDD Partners, LLC 783,697$3,385,5710.49%
ARK Investment Management 11,509,308$62,725,7280.48%
Nikko Asset Management Americas, Inc. 6,570,939$35,680,1990.43%
Triatomic Management LP 102,889$560,7450.39%
View complete list of ADAPTIVE BIOTECHNOLOGIES COR shareholders